PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsRenal tubular acidosis
MeSH D000141 - renal tubular acidosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D015499:Inborn errors renal tubular transport
0 Companies
0 Drugs
Success rate
D000138:Acidosis
$
Success rate
D000141: 
Renal tubular acidosis
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
BaxterCitric acid monohydrate Irrigating Solution G  1982-06-22   
Sodium chloride, Sodium bicarbonate Phoxillum B22k  2015-01-13   
Dextrose, Lactic acid, Sodium chloride, Sodium bicarbonate Prismasol  2006-10-25   
Evofem BiosciencesCitric acid monohydrate, Lactic acid Phexxi 2024-03-06 2020-05-22   
Eywa PharmaPotassium citrate Potassium  2021-02-19   
Ferring PharmaceuticalsCitric acid monohydrate Clenpiq 2034-06-23 2017-11-28   
Citric acid monohydrate Prepopik 2028-10-10 2012-07-16   
HeteroCitric acid monohydrate Picosulfate, Magnesium Oxide Anhydrous Citric Acid  2022-07-18   
HospiraCitric acid monohydrate Urologic G  1983-05-27   
MylanPolyethylene glycol 3350, Tezacitabine, Sodium chloride, Sodium bicarbonate Colyte With Flavor Packs  1984-10-26   
Nostrum LaboratoriesPolyethylene glycol 3350, Sodium chloride, Sodium bicarbonate Peg, Potassium Chloride, Bicarbonate,  2017-03-08   
Rising PharmaceuticalsPolyethylene glycol 3350, Tezacitabine, Sodium chloride, Sodium bicarbonate Peg 3350 Electrolytes  2010-01-28   
Polyethylene glycol 3350, Sodium chloride, Sodium bicarbonate Peg, Potassium Chloride, Bicarbonate,  2010-04-02   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
0%
0/0
Phase 3
100%
2/2
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Baxter
Evofem Biosciences
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use